ACADIA Pharmaceuticals Inc. (ACAD)

ACADIA Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 27, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	2,820	5,140	2,578	3,752	8,499	6,589
Market Cap Growth	-25.23%	99.40%	-31.29%	-55.85%	28.98%	183.72%
Enterprise Value	2,304	4,852	2,204	3,278	7,904	5,916
Last Close Price	16.95	31.31	15.92	23.34	53.46	42.78
Forward PE	33.16	27.40	-	-	-	-
PS Ratio	3.01	7.08	4.98	7.75	19.24	19.43
PB Ratio	4.89	11.91	6.44	6.94	13.55	9.42
P/TBV Ratio	5.41	14.03	6.44	6.94	13.58	9.46
P/FCF Ratio	13.92	308.70	-	-	-	-
P/OCF Ratio	13.91	307.78	-	-	-	-
EV/Sales Ratio	2.48	6.68	4.26	6.77	17.89	17.45
EV/FCF Ratio	11.37	291.36	-	-	-	-
Debt / Equity Ratio	0.09	0.13	0.15	0.12	0.08	0.01
Debt / FCF Ratio	0.24	3.44	-	-	-	-
Asset Turnover	1.15	1.09	0.80	0.65	0.56	0.51
Inventory Turnover	8.49	18.53	51.21	29.44	35.81	49.94
Quick Ratio	1.96	2.13	3.82	6.10	6.44	9.83
Current Ratio	2.29	2.42	4.04	6.43	6.77	10.16
Return on Equity (ROE)	27.36%	-14.73%	-45.89%	-28.75%	-42.47%	-39.93%
Return on Assets (ROA)	8.72%	-6.86%	-21.70%	-14.37%	-18.66%	-23.29%
Return on Capital (ROIC)	13.41%	-9.64%	-26.18%	-16.62%	-21.09%	-25.94%
Earnings Yield	4.56%	-1.19%	-8.38%	-4.47%	-3.31%	-3.57%
FCF Yield	7.19%	0.32%	-4.42%	-3.38%	-1.69%	-2.31%
Buyback Yield / Dilution	-1.65%	-1.32%	-0.74%	-2.01%	-6.88%	-16.29%
Total Shareholder Return	-1.65%	-1.32%	-0.74%	-2.01%	-6.88%	-16.29%

Source: S&P Capital IQ. Standard template. Financial Sources.